Sarilumab Improves Quality of Life in Polymyalgia Rheumatica

Okay, here’s an original, ⁢people-first article based on the provided information, ready for publication:

Hope for PMR Patients: Sarilumab shows‍ Promise in Improving Quality of Life

September 11, 2025 – For individuals battling polymyalgia rheumatica (PMR), a painful and frequently enough debilitating inflammatory condition, new research ‌offers​ a beacon of hope. A recent study⁣ published in The Lancet Rheumatology reveals that sarilumab, in conjunction with a shorter glucocorticoid taper, can significantly improve quality of life and patient-reported outcomes ‌compared to conventional treatment approaches.

PMR, characterized by muscle pain and stiffness, particularly in the shoulders and⁣ hips, often necessitates long-term treatment with glucocorticoids (steroids). While⁢ effective in managing symptoms, these steroids can come with a host of unwelcome side effects, impacting patients’ overall well-being.

The new study investigated